Cancer therapies come at a high price, resulting in an even greater incentive for maintaining an income and health insurance coverage, but patients still face a multitude of barriers when returning to work after a cancer diagnosis.
Because of the growing prevalence of cancer survivorship, the financial burden of cancer is becoming increasingly overwhelming for patients not only immediately after a cancer diagnosis, but often many years after treatment, said K. Robin Yabroff, PhD, MBA, of the American Cancer Society.
According to findings from a national representative sample presented at the 2018 Cancer Survivorship Symposium, fear of cancer recurrence is prevalent among cancer survivors, but may only be experienced by a minority of patients.
To effectively address socioeconomic disparities in healthcare, it is critical that we improve our understanding of the material, psychosocial, and behavioral dimensions of financial well-being, said Reginald D. Tucker-Seeley, MA, ScM, ScD, at the 2017 AACR Science of Cancer Health Disparities Conference.
A survivorship visit and care plan are mandated for breast cancer survivors by the National Accreditation Program for Breast Centers. These initiatives have improved the quality of follow-up care for cancer survivors and patient satisfaction, but survivorship programs are a work in progress, and some challenges remain as they evolve.
Guided by advances in genomic technology, healthcare has entered the era of precision medicine. With genetic testing now standard of care in oncology practice, cancer is at the forefront of this initiative, but providers still face many concerns.